Literature DB >> 10659871

Prognostic value of pololike kinase expression in melanomas.

K Strebhardt, L Kneisel, C Linhart, A Bernd, R Kaufmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10659871     DOI： 10.1001/jama.283.4.479

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  30 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

Review 2.  Targeting polo-like kinase 1 in acute myeloid leukemia.

Authors:  Joseph M Brandwein
Journal:  Ther Adv Hematol       Date:  2015-04

3.  Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.

Authors:  Chunling Zhao; Lei Gong; Wentong Li; Limei Chen
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

Review 4.  Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.

Authors:  Jijing Luo; Xiaoqi Liu
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

5.  Normal cells, but not cancer cells, survive severe Plk1 depletion.

Authors:  Xiaoqi Liu; Ming Lei; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

Authors:  Masaki Nogawa; Takeshi Yuasa; Shinya Kimura; Motoyoshi Tanaka; Junya Kuroda; Kiyoshi Sato; Asumi Yokota; Hidekazu Segawa; Yoshinobu Toda; Susumu Kageyama; Tatsuhiro Yoshiki; Yusaku Okada; Taira Maekawa
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

Review 7.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Direct quantification of polo-like kinase 1 activity in cells and tissues using a highly sensitive and specific ELISA assay.

Authors:  Jung-Eun Park; Luowei Li; Joobae Park; Rainald Knecht; Klaus Strebhardt; Stuart H Yuspa; Kyung S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

Review 9.  Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications.

Authors:  Ion Cristóbal; Federico Rojo; Juan Madoz-Gúrpide; Jesús García-Foncillas
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

Review 10.  Melanoma biomarkers: current status and vision for the future.

Authors:  Allison R Larson; Eliz Konat; Rhoda M Alani
Journal:  Nat Clin Pract Oncol       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.